The Clinical Value of Cardiopulmonary Exercise Testing in the Modern Era

Overview

Journal Eur Respir Rev

Specialty Pulmonary Medicine

Date 2021 Jan 7

PMID 33408087

Citations 22

Authors

Pierantonio Laveneziana

Marcello Di Paolo

Paolo Palange

Affiliations

Soon will be listed here.

Abstract

Cardiopulmonary exercise testing (CPET) has long been used as diagnostic tool for cardiac diseases. During recent years CPET has been proven to be additionally useful for 1) distinguishing between normal and abnormal responses to exercise; 2) determining peak oxygen uptake and level of disability; 3) identifying factors contributing to dyspnoea and exercise limitation; 4) differentiating between ventilatory (respiratory mechanics and pulmonary gas exchange), cardiovascular, metabolic and peripheral muscle causes of exercise intolerance; 5) identifying anomalies of ventilatory (respiratory mechanics and pulmonary gas exchange), cardiovascular and metabolic systems, as well as peripheral muscle and psychological disorders; 6) screening for coexistent ischaemic heart disease, peripheral vascular disease and arterial hypoxaemia; 7) assisting in planning individualised exercise training; 8) generating prognostic information; and 9) objectively evaluating the impact of therapeutic interventions. As such, CPET is an essential part of patients' clinical assessment. This article belongs to the special series on the "Ventilatory efficiency and its clinical prognostic value in cardiorespiratory disorders", addressed to clinicians, physiologists and researchers, and aims at encouraging them to get acquainted with CPET in order to help and orient the clinical decision concerning individual patients.

Citing Articles

Comparing methods to measure the dispersion of breathing parameters during exercise testing: A simulation study based on real-life parameters from patients with dysfunctional breathing.

Genecand L, Jaksic C, Desponds R, Simian G, Guerreiro I, Thorens S Physiol Rep. 2025; 13(5):e70233.

PMID: 40019840 PMC: 11870078. DOI: 10.14814/phy2.70233.

Reference Data for a Treadmill-Based Peak Oxygen Uptake (VO) in Older Adults.

Sagat P Biology (Basel). 2025; 14(2).

PMID: 40001896 PMC: 11851712. DOI: 10.3390/biology14020128.

Comparing the Physiological Responses to the 6-Minute Walk Test, Timed Up and Go Test, and Treadmill Cardiopulmonary Exercise Test.

Alves E, Bellet R, Sharma P, Balmain B, Aitken C, Doering T Rehabil Res Pract. 2024; 2024:1317817.

PMID: 39376726 PMC: 11458269. DOI: 10.1155/2024/1317817.

A case report of cardiopulmonary exercise testing and incentive spirometry-guided breathing pattern alteration for a severely tachypnoeic kyphoscoliotic patient undergoing major thoracic surgery for suspected lung malignancy.

Wong A, Lam C SAGE Open Med Case Rep. 2024; 12:2050313X241275384.

PMID: 39290560 PMC: 11406589. DOI: 10.1177/2050313X241275384.

Identifying limitations to exercise with incremental cardiopulmonary exercise testing: a scoping review.

Staes M, Gyselinck I, Goetschalckx K, Troosters T, Janssens W Eur Respir Rev. 2024; 33(173).

PMID: 39231595 PMC: 11372471. DOI: 10.1183/16000617.0010-2024.

References

Weatherald J, Boucly A, Montani D, Jais X, Savale L, Humbert M . Gas Exchange and Ventilatory Efficiency During Exercise in Pulmonary Vascular Diseases. Arch Bronconeumol (Engl Ed). 2020; 56(9):578-585. DOI: 10.1016/j.arbres.2019.12.030. View

Urban R, Bodenburg Y, Gilkison C, Foxworth J, Coggan A, Wolfe R . Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995; 269(5 Pt 1):E820-6. DOI: 10.1152/ajpendo.1995.269.5.E820. View

Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis M . Effects of testosterone and resistance training in men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 170(8):870-8. DOI: 10.1164/rccm.200305-617OC. View

Johnson B, Weisman I, Zeballos R, Beck K . Emerging concepts in the evaluation of ventilatory limitation during exercise: the exercise tidal flow-volume loop. Chest. 1999; 116(2):488-503. DOI: 10.1378/chest.116.2.488. View

Laveneziana P, Agostoni P . Exertional dyspnoea in cardiorespiratory disorders: the clinical use of cardiopulmonary exercise testing. Eur Respir Rev. 2016; 25(141):227-9. PMC: 9487217. DOI: 10.1183/16000617.0044-2016. View

Laveneziana P, Webb K, Ora J, Wadell K, ODonnell D . Evolution of dyspnea during exercise in chronic obstructive pulmonary disease: impact of critical volume constraints. Am J Respir Crit Care Med. 2011; 184(12):1367-73. DOI: 10.1164/rccm.201106-1128OC. View

. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med. 2003; 167(2):211-77. DOI: 10.1164/rccm.167.2.211. View

Laveneziana P, Garcia G, Joureau B, Nicolas-Jilwan F, Brahimi T, Laviolette L . Dynamic respiratory mechanics and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2012; 41(3):578-87. DOI: 10.1183/09031936.00223611. View

. Clinical exercise testing with reference to lung diseases: indications, standardization and interpretation strategies. ERS Task Force on Standardization of Clinical Exercise Testing. European Respiratory Society. Eur Respir J. 1998; 10(11):2662-89. DOI: 10.1183/09031936.97.10112662. View

10.

Puente-Maestu L, Palange P, Casaburi R, Laveneziana P, Maltais F, Neder J . Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016; 47(2):429-60. DOI: 10.1183/13993003.00745-2015. View

11.

Palange P, Ward S, Carlsen K, Casaburi R, Gallagher C, Gosselink R . Recommendations on the use of exercise testing in clinical practice. Eur Respir J. 2007; 29(1):185-209. DOI: 10.1183/09031936.00046906. View

12.

Radtke T, Crook S, Kaltsakas G, Louvaris Z, Berton D, Urquhart D . ERS statement on standardisation of cardiopulmonary exercise testing in chronic lung diseases. Eur Respir Rev. 2019; 28(154). PMC: 9488712. DOI: 10.1183/16000617.0101-2018. View

13.

Casaburi R, Patessio A, Ioli F, Zanaboni S, Donner C, Wasserman K . Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991; 143(1):9-18. DOI: 10.1164/ajrccm/143.1.9. View

14.

Laviolette L, Laveneziana P . Dyspnoea: a multidimensional and multidisciplinary approach. Eur Respir J. 2014; 43(6):1750-62. DOI: 10.1183/09031936.00092613. View

15.

Laveneziana P, Humbert M, Godinas L, Joureau B, Malrin R, Straus C . Inspiratory muscle function, dynamic hyperinflation and exertional dyspnoea in pulmonary arterial hypertension. Eur Respir J. 2015; 45(5):1495-8. DOI: 10.1183/09031936.00153214. View

16.

Laveneziana P, Innocenti Bruni G, Presi I, Stendardi L, Duranti R, Scano G . Tidal volume inflection and its sensory consequences during exercise in patients with stable asthma. Respir Physiol Neurobiol. 2012; 185(2):374-9. DOI: 10.1016/j.resp.2012.08.026. View

17.

Laveneziana P, Webb K, Wadell K, Neder J, ODonnell D . Does expiratory muscle activity influence dynamic hyperinflation and exertional dyspnea in COPD?. Respir Physiol Neurobiol. 2014; 199:24-33. DOI: 10.1016/j.resp.2014.04.005. View

18.

Lewis M, Horvitz G, Clemmons D, Fournier M . Role of IGF-I and IGF-binding proteins within diaphragm muscle in modulating the effects of nandrolone. Am J Physiol Endocrinol Metab. 2002; 282(2):E483-90. DOI: 10.1152/ajpendo.00191.2001. View

19.

Huckstepp R, Cardoza K, Henderson L, Feldman J . Distinct parafacial regions in control of breathing in adult rats. PLoS One. 2018; 13(8):e0201485. PMC: 6086409. DOI: 10.1371/journal.pone.0201485. View

20.

Lewis M, Fournier M, Storer T, Bhasin S, Porszasz J, Ren S . Skeletal muscle adaptations to testosterone and resistance training in men with COPD. J Appl Physiol (1985). 2007; 103(4):1299-310. DOI: 10.1152/japplphysiol.00150.2007. View